What sector does Core Laboratories belong to?

Core Laboratories operates in the Energy sector, specifically the Oil & Gas Equipment & Services industry, and is listed on the US markets.

What is the current share price of CLB?

As of the latest available quote, CLB traded at $12.50. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of CLB?

Core Laboratories has a price-to-earnings (P/E) ratio of about 24.04. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of CLB?

The market capitalisation of Core Laboratories is approximately $588.67M.

Is Core Laboratories profitable?

For its latest reported financial year, Core Laboratories recorded a net profit margin of about 5.63%.

Does CLB pay a dividend?

Core Laboratories currently has a dividend yield of about 0.32%.

What is the return on equity (ROE) of CLB?

Core Laboratories has a return on equity (ROE) of about 10.88%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of CLB?

Over the past 52 weeks, CLB has traded between a low of $9.79 and a high of $20.36.

Core Laboratories

CLB US Energy Oil & Gas Equipment & Services

S&P 600

$12.50

-0.24%

Delayed · cached 15 min

Fair value analysis

CLB

Core Laboratories

$12.50

Close used for this calculation

$12.58Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

60/100

Profitability15/25

Returns13/25

Balance Sheet21/25

Efficiency11/25

Growth8/25

Good

Quality radar

Consensus fair value

$12.58

Near FV

▲ +0.6% against the close used

Model range $6.72 – $21.30

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$6.72Fair value$12.58Bull$21.30

FairClose

52-week traded range

52W low $9.8752W high $19.67

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

Core Laboratories closed at $12.50, 0.6% below the consensus fair value of $12.58 drawn from 7 valuation models.

Financial DNA score 60/100 — Good. P/E of 19.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$10.88

-12.9%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

P/E Fair Value

$12.60

+0.8%

EPS × 20x (sector P/E)

EPS=0.63, Sector P/E=20x

Peter Lynch (PEG)

$6.72

-46.2%

EPS × Growth% (PEG = 1 is fair)

EPS=0.63, g=10.7%

EV/EBITDA

$21.30

+70.4%

(EBITDA × 15.3x − Net Debt) ÷ Shares

EBITDA=71.12M

Book Value (P/B)

$7.09

-43.3%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=5.81, ROE=10.9%, g=6%, r=10%

Reverse DCF

$12.50

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 7% | Historical: 10.7%

Margin of Safety

$8.81

-29.6%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=11.74, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer